Global Markets
Home›Global Markets›North America›Already jumped 55% in 2026, PL Capital sees more retur…
Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside
PL Capital believes the company is well positioned to benefit from increasing pharmaceutical outsourcing, a deep commercial pipeline and capacity expansion
← Newer storyHedge funds suffer broadest daily losses since Covid as tech stocks t…Older story →UK PMI Composite Hits Eight-Month High as Hiring Returns After Two Ye…